157 related articles for article (PubMed ID: 2084460)
1. Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal.
Tishler PV; Winston SH
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):645-8. PubMed ID: 2084460
[TBL] [Abstract][Full Text] [Related]
2. Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Gorchein A; Guo R; Lim CK; Raimundo A; Pullon HW; Bellingham AJ
Biomed Chromatogr; 1998; 12(6):350-6. PubMed ID: 9861496
[TBL] [Abstract][Full Text] [Related]
3. Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro.
Tishler PV; Winston SH
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):485-91. PubMed ID: 4079600
[TBL] [Abstract][Full Text] [Related]
4. The effect of oral activated charcoal on the course of congenital erythropoietic porphyria.
Hift RJ; Meissner PN; Kirsch RE
Br J Dermatol; 1993 Jul; 129(1):14-7. PubMed ID: 8369205
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria.
Pimstone NR; Gandhi SN; Mukerji SK
N Engl J Med; 1987 Feb; 316(7):390-3. PubMed ID: 3100953
[No Abstract] [Full Text] [Related]
6. A plasma porphyrin fluorescence marker for variegate porphyria.
Poh-Fitzpatrick MB
Arch Dermatol; 1980 May; 116(5):543-7. PubMed ID: 7377785
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
Kalb RE; Grossman ME; Poh-Fitzpatrick MB
Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
[TBL] [Abstract][Full Text] [Related]
8. Oral charcoal therapy of congenital erythropoietic porphyria.
Tishler PV
Hepatology; 1988; 8(1):183-4. PubMed ID: 3338705
[No Abstract] [Full Text] [Related]
9. Biochemical diagnosis and monitoring therapeutic modulation of disease activity in an unusual case of congenital erythropoietic porphyria.
Mukerji SK; Pimstone NR; Gandhi SN; Tan KT
Clin Chem; 1985 Dec; 31(12):1946-51. PubMed ID: 4064282
[TBL] [Abstract][Full Text] [Related]
10. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria.
Eriksen L; Eriksen N
Scand J Clin Lab Invest; 1974 Jun; 33(4):323-32. PubMed ID: 4853698
[No Abstract] [Full Text] [Related]
11. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
[TBL] [Abstract][Full Text] [Related]
12. Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
Winston SH; Tishler PV
Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):233-7. PubMed ID: 3724299
[TBL] [Abstract][Full Text] [Related]
13. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.
Watson CJ; Bossenmaier I; Cardinal R; Petryka ZJ
Proc Natl Acad Sci U S A; 1974 Feb; 71(2):278-82. PubMed ID: 4521800
[TBL] [Abstract][Full Text] [Related]
14. Porphyria variegata: failure of chloroquin treatment.
Cramers M; Jepsen LV
Acta Derm Venereol; 1980; 60(1):89-91. PubMed ID: 6153849
[TBL] [Abstract][Full Text] [Related]
15. [Carbolen in the treatment of late porphyria of the skin].
Pankov BS
Vestn Dermatol Venerol; 1967 Apr; 41(4):67-70. PubMed ID: 5611845
[No Abstract] [Full Text] [Related]
16. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
Raff M; Formanek I
Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and clinical application of the Enterotest for the determination of human biliary porphyrin composition.
Beukeveld GJ; Bijleveld CM; Kuipers F; Kreeftenberg HG; Huizenga JR; te Velde K; Wolthers BG
Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):453-62. PubMed ID: 7548456
[TBL] [Abstract][Full Text] [Related]
18. Administration of oral activated charcoal in variegate porphyria results in a paradoxical clinical and biochemical deterioration.
Hift RJ; Todd G; Meissner PN; Kirsch RE
Br J Dermatol; 2003 Dec; 149(6):1266-9. PubMed ID: 14674906
[TBL] [Abstract][Full Text] [Related]
19. Congenital erythropoietic porphyria. A case report with discussion of different porphyrin excretion patterns.
Dahle JS; Eriksen L; Romslo I; Thune P
Photodermatol; 1984 Aug; 1(4):187-90. PubMed ID: 6531292
[TBL] [Abstract][Full Text] [Related]
20. The first Swedish case of congenital erythropoietic porphyria, with a revised view of the porphyrin excretion pattern in this disease.
Stenberg B; With TK
Acta Derm Venereol Suppl (Stockh); 1982; 100():87-90. PubMed ID: 6962640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
